Recent Headlines
AnaSpec Signs Distribution Agreement with Yope Biotechnology
AnaSpec and Yope Biotechnology Co. Ltd. today announced a non-exclusive distributor agreement that will allow Yope Biotechnology Co. Ltd. to distribute AnaSpec’s catalog and custom products throughout China. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted,... - December 04, 2008 - AnaSpec, EGT Group
AnaSpec Signs Distribution Agreement with Biogenuix Medsystems
AnaSpec and Biogenuix Medsystems Pvt. Ltd. today announced a non-exclusive distributor agreement that will allow Biogenuix Medsystems Pvt. Ltd. to distribute AnaSpec’s catalog and custom products throughout India. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted,... - November 28, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New Line of LL-37 GO™ Peptides
LL-37 peptides are AnaSpec’s latest addition to their expansive collection of research-ready, on-demand GO™ Peptides. - November 27, 2008 - AnaSpec, EGT Group
AnaSpec Releases 4 New Phosphospecific Anti-Tau Antibodies
AnaSpec is excited to announce the release of 4 more new phosphospecific anti-Tau antibodies. This represents the industry’s largest collection of anti-Tau antibodies - 17 phosphospecific and 9 non-phosphospecific antibodies. AnaSpec’s expertise in phosphopeptide synthesis combined... - November 23, 2008 - AnaSpec, EGT Group
AnaSpec Signs Distribution Agreement with Shanghai Universal Biotech Company
AnaSpec and Shanghai Universal Biotech Company today announced a non-exclusive distributor agreement that will allow Shanghai Universal Biotech Company to distribute AnaSpec’s catalog and custom products throughout China. - November 22, 2008 - AnaSpec, EGT Group
AnaSpec Establishes New Dedicated GMP Manufacturing Facility
In response to increased demand for GMP peptide production, AnaSpec has established a new facility dedicated to GMP manufacturing. Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000 sq. ft. of dedicated GMP space including two class... - November 16, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Series of Luminescent and Non-Luminescent Calcium Indicators
AnaSpec offers coelenterazine and several synthetic coelenterazine analogs for reconstituting aequorin in cells that have been transfected with apoaequorin cDNA. - November 14, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Improved AnaTagTM APC, B-PE and R-PE Labeling Kits
AnaSpec is pleased to announce the release of the improved AnaTagTM APC, B-PE and R-PE Labeling Kits. Labeling of antibodies can be both tedious and time-consuming. Without the use of proper techniques and reagents, the conjugation may result in suboptimal or no labeling. AnaSpec’s improved... - November 12, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Fluorescent Calcium Indicators
Calcium plays a vital role in the regulation of cardiac contractility, growth and gene expression; consequently, calcium measurement is critical in numerous biological investigations. Fluorescent probes that show spectral responses upon Ca2+ binding have enabled researchers to investigate changes... - November 05, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New PKD1 & PKD2 Antibodies
Protein kinase D (PKD belongs to the calcium calmodulin superfamily of kinases (2-3). - October 23, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyteTM MMP ELISA Kits
MMPs are key players in normal and pathological processes, including embryogenesis, wound healing, inflammation, arthritis, and cancer. - October 18, 2008 - AnaSpec, EGT Group
AnaSpec’s FRET Feature Article Available at Photonics.com
AnaSpec published a technical article entitled, “Sensitive FRET Assays Aid Drug Discovery” in the August edition of Biophotonics International. - October 16, 2008 - AnaSpec, EGT Group
BellBrook Labs Announces a Kinase/ATPase Assay That is "2" Sensitive
The Transcreener ADP2 FP Assay is a homogenous fluorescence polarization assay that enables the facile detection and screening of established drug targets including protein and lipid kinases as wells as emerging targets such as heat shock proteins and other ATPases. - October 15, 2008 - BellBrook Labs
AnaSpec Introduces Histone GO™ Peptides - Acetylated & Methylated
The core histones (H2A, H2B, H3 and H4) act as spools around which DNA winds. Covalent modification on the amino terminal of the core histones through de/acetylation, de/methylation and de/phosphorylation affect chromatin structure and exquisitely regulate gene expression.1-3 Histone... - October 11, 2008 - AnaSpec, EGT Group
TBTA - Click Chemistry Ligand for Cu (I)
Copper (I) species are powerful catalysts for the formation of 1,2,3-triazoles from azides and alkynes. The general thermodynamic instability of Cu(I) however, results in easy oxidation to Cu(II) and/or disproportionation to Cu(0) and Cu(II).1 TBTA, Tris-[(1-benzyl-1H-1,2,3-triazol-4-yl)... - September 24, 2008 - AnaSpec, EGT Group
AnaSpec Celebrates 15 Year Anniversary
Since its inception in 1993, AnaSpec has provided drug discovery reagents to some of the world’s largest biotech, pharmaceutical, and academic research institutions. - September 21, 2008 - AnaSpec, EGT Group
AnaSpec to Manufacture BD™ Fluorescent Dyes for BD Biosciences
AnaSpec announced today that BD Biosciences, a business segment of BD (Becton Dickinson and Company), has chosen it to manufacture and supply the BD™ H7, Calcein AM and DiIC12(3) Fluorescent Dyes. “BD Biosciences has a tremendous reputation in the industry for innovative products of... - September 19, 2008 - AnaSpec, EGT Group
AnaSpec Introduces High Performance Labeled Streptavidins
AnaSpec has introduced its latest collection of streptavidins labeled with its patented HiLyte Fluor(TM) and HiLytePlus(TM) dyes which promise brighter fluorescence and better photostability compared to FITC and Cyâ dyes. - September 18, 2008 - AnaSpec, EGT Group
RayBiotech and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
AnaSpec and RayBiotech today announced a licensing agreement that will allow RayBiotech to label antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes and integrate into protein and antibody arrays. HiLytePlus™ and HiLyte Fluor™ are AnaSpec's proprietary series of high... - September 17, 2008 - AnaSpec, EGT Group
AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits
AnaSpec and Cyclex Co. Ltd. today announced a licensing agreement that will allow AnaSpec to make, use, and sell deacetylase activity assay kits and the related products as covered by Cyclex’s patent # ‘s EP 1243658, US 7033778, US 7256013. "We are pleased to partner with Cyclex... - September 14, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Kinase Substrates as GO™ Peptides
Protein kinases are a transferase family of self-regulatory enzymes that catalyze the phosphorylation of other proteins by covalently attaching phosphate groups to them, using ATP as a phosphate donor. Reversible protein phosphorylation-dephosphorylation has a principal role in the regulation of... - September 11, 2008 - AnaSpec, EGT Group
Recombinant MOG Proteins - New
Expanding on its world-class collection of MOG peptides and assay kits, AnaSpec is pleased to announce the release of 3 MOG recombinant proteins, for human, mouse and rat. These proteins, with sequences corresponding to human, mouse and rat extracellular domain, together with a 6x His tag were... - September 10, 2008 - AnaSpec, EGT Group
Anavex Completes Successful Preclinical Studies on Lead Alzheimer's Drug Candidate
Anavex completes successful preclinical studies on Anavex 2-73, a novel sigma-1 receptor agonist for the treatment of Alzheimer's disease. - September 04, 2008 - Anavex Life Sciences Corp.
AnaSpec Peptides Used in Latest Alzheimer’s Research Findings by VU University Medical Centre and Lund University
At the 2008 International Conference for Alzheimer’s Disease, the VU University Medical Centre and Lund University presented a joint poster entitled, “Aβ1-42 binding and uptake by primary human astrocytes in vitro: Effects of a1-Antichymotrypsin.” The authors of the study... - August 31, 2008 - AnaSpec, EGT Group
New Anti-GHSR Antibodies from AnaSpec
AnaSpec has announced the release of two antibodies for growth secretagogue receptor (GHSR). One antibody targets the N-terminus and the other an internal sequence. GHSR is a G protein-coupled receptor with seven transmembrane domains and is primarily expressed in hypothalamus and pituitary glands... - August 30, 2008 - AnaSpec, EGT Group
AnaSpec and UW TechTransfer Sign Licensing Agreement for Protein Tyrosine Phosphatases
AnaSpec and UW TechTransfer today announced a licensing agreement that will allow AnaSpec to make, use, and sell Protein Tyrosine Phosphatase Substrates as covered by UW’s patent # 5,739,278 entitled “Compositions for Protein Tyrosine Phosphatases.” "We are pleased to... - August 29, 2008 - AnaSpec, EGT Group
Biocore and AnaSpec Sign Distributor Agreement
AnaSpec and Biocore Pty Ltd today announced a non-exclusive distributor agreement that will allow Biocore Pty Ltd to distribute AnaSpec’s catalog and custom products throughout Australia. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec is pleased... - August 14, 2008 - AnaSpec, EGT Group
AnaSpec Introduces GO Peptides™ - Research-Ready Peptides on Demand
AnaSpec is pleased to introduce GO Peptides™, the next evolution in peptide tools. - August 13, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte™ 570 Generic MMP Assay Kit with Industry’s Highest Wavelength
Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components. The importance of MMPs in tumor development and invasion as well as other diseases is well known. AnaSpec has introduced the SensoLyteTM 570 Generic... - August 09, 2008 - AnaSpec, EGT Group
Anavex Presents Neuroprotective Effects of Anavex 1-41 at the International Conference on Alzheimer's Disease 2008
Anavex Life Sciences presented its new findings of its ANAVEX 1-41 compound targeting Alzheimer's disease at ICAD (July 26 to 31, 2008). - August 02, 2008 - Anavex Life Sciences Corp.
Novus Biologicals and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
AnaSpec and Novus Biologicals today announced a licensing agreement that will allow Novus Biologicals to label Novus antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes. HiLytePlus™ and HiLyte Fluor™ are AnaSpec's proprietary series of high performance fluorescent... - July 30, 2008 - AnaSpec, EGT Group
AnaSpec Offers Custom Peptide-Aminoluciferin Synthesis
AnaSpec now offers custom synthesis service of peptide-aminoluciferin substrates. - July 23, 2008 - AnaSpec, EGT Group
Korea's Largest Biotech Show Kicks Off in Osong
The 3rd BIO KOREA convention will be held from October 8th to 10th at Osong Bio-Technopolis. The event of this year offers a variety of high-level conference, international exhibition and partnership events and provide an opportunity to find business and technology partners. It expects to 350 companies and 25,000 visitors from all over the world. - July 17, 2008 - Bio Korea
Anavex Life Sciences Corp. Will Present New Findings at the International Conference on Alzheimer's Disease 2008 (July 26-31, 2008, Chicago, USA)
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) announces its participation at the International Conference on Alzheimer's Disease 2008 (July 26-31, 2008, Chicago, USA), where it will present results obtained with Anavex 1-41 demonstrating a protective effect against the neurotoxicity... - July 15, 2008 - Anavex Life Sciences Corp.
AnaSpec Introduces New Series of PAR Peptides
AnaSpec has introduced its latest series of PAR peptides. - July 09, 2008 - AnaSpec, EGT Group
New Anti-Keratin Antibodies Introduced by AnaSpec
AnaSpec has introduced two keratin antibodies that recognize both the intact and caspase digested N-terminal of K18 and K19 at Asp237. These antibodies are useful tools for studying keratin dynamics in mice undergoing hepatocyte apoptosis, patients with cirrhosis, and also in apoptotic cells of... - July 04, 2008 - AnaSpec, EGT Group
New SensoLyte HDAC Assay Kit Introduced by AnaSpec
Histone deacetylase (HDAC) enzymes modulate gene expression through the deacetylation of lysine residues on histone proteins and act as transcriptional repressors of genes. Based on their role in cell cycling, apoptosis and differentiation, HDACs have been chosen as therapeutic targets for the... - June 27, 2008 - AnaSpec, EGT Group
AnaSpec Offers Custom Synthesis of Hydrocarbon-Stapled Peptides
The innovative technique of hydrocarbon stapling in peptides is introducing valuable new functionality to peptide-related research. AnaSpec is pleased to offer custom synthesis for hydrocarbon-stapled peptides. Hydrocarbon-stapled peptides are peptides capable of forming stable alpha helical... - June 20, 2008 - AnaSpec, EGT Group
Anavex Further Strengthens Board of Directors
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) today announced the appointment of David L. Tousley, CPA, MBA, to its Board of Directors. Mr. Tousley is an accomplished professional with many years of experience as a senior financial and operations executive in start-up and... - June 20, 2008 - Anavex Life Sciences Corp.
New Anti-CARMA Antibody Series Released by AnaSpec
AnaSpec has introduced a new series of IHC validated antibodies, Anti-CARMA/CARD/Bimp antibodies. CARMA proteins are scaffold molecules that belong to the membrane-associated guanylate kinase-like (MAGUK) and the caspase-associated recruitment domain (CARD) protein families. They play critical... - June 19, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Eleven New Peptides
This week AnaSpec, a world leader in custom and catalog peptides, introduced eleven (11) new peptides. - June 18, 2008 - AnaSpec, EGT Group
New SensoLyte™ 520 Cathepsin S Assay Kit Introduced by AnaSpec
AnaSpec has introduced the SensoLyte™ 520 Cathepsin S Assay Kit to its broad collection of long wavelength FRET protease assay kits. - May 29, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Sixty New Peptides & 3 New Assay Kits
This week, AnaSpec introduced sixty (60) new catalog peptides and three (3) new assay kits. - May 27, 2008 - AnaSpec, EGT Group
AnaSpec Introduces 8 New Antibody Products
AnaSpec added eight (8) new antibody products to its growing collection. - May 24, 2008 - AnaSpec, EGT Group
Anavex Announces Appointment of Oncology Specialist to Board of Directors, Changes to Executive Management
Anavex Life Sciences Corp. ("ANAVEX'') (OTC BB:AVXL.OB) today announced the appointment of Alison Ayers to its Board of Directors. Ms. Ayers is currently the Worldwide Commercial Head for Oncology at Pfizer, with responsibility for Pfizer's oncology portfolio, which includes more than 20 drug... - May 23, 2008 - Anavex Life Sciences Corp.
AnaSpec Introduces ClearPoint™ Heavy Isotope-Labeled Peptides
AnaSpec has introduced ClearPoint™ Peptides, heavy isotope-labeled peptides for absolute quantitation (AQUA) of proteins. - May 18, 2008 - AnaSpec, EGT Group
AnaSpec’s Published References Passes 600
The number of published papers that cite AnaSpec’s products has passed 600. - May 04, 2008 - AnaSpec, EGT Group
AnaSpec Presents Fluorimetric TACE Detection Poster at SBS Conference
AnaSpec presented its latest findings in regards to the detection of TACE activity using FRET technology. - May 03, 2008 - AnaSpec, EGT Group
AnaSpec Introduces a Suite of Phospho-Specific Anti-Her2 Antibodies
AnaSpec has introduced a full suite of phospho-specific ErbB-2 (Her-2) polyclonal antibodies. - April 30, 2008 - AnaSpec, EGT Group
AnaSpec Introduces 13 New Antibody Products
AnaSpec added thirteen (13) new antibody products to its growing collection. - April 25, 2008 - AnaSpec, EGT Group